Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Glaxo Wellcome receives E.U. approval for Seretide MDI for the treatment of asthma

Dec. 29, 2000

NDA submitted to FDA for rapidly disintegrating desloratadine tablets

Dec. 29, 2000

Takeda discloses compounds with potent adenosine A3 receptor-antagonist activity

Dec. 28, 2000

Meiji Milk and Takeda to codevelop MT-201 for treatment of cryptomeria pollinosis

Dec. 28, 2000

Sumitomo reports quinazoline derivatives with potential for allergic disease treatment

Dec. 27, 2000

Inflazyme's novel asthma therapy enters phase II following U.K. approval

Dec. 27, 2000

Pyrazole derivatives from Yamanouchi inhibit CRACC and IL-2 production

Dec. 22, 2000

Schering-Plough to market pranlukast in Latin America

Dec. 22, 2000

Anti-IL-9 antibody collaboration terminated by Genentech

Dec. 22, 2000

PDE7 inhibitors and their use presented by Darwin Discovery

Dec. 19, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...